A series of webinars will highlight recent applications of advanced text analytics in industry-leading pharmaceutical and life sciences companies
BLOOMINGTON, Ind., Jan. 19, 2017 (GLOBE NEWSWIRE) — Megaputer Intelligence announced today that it will host a live webinar series titled “Text Analytics for Pharma” beginning on January 31, 2017. A set of nine free webinars comprising this series will highlight how advanced text analytics helps address typical challenges encountered in the pharmaceutical and life sciences domains:
- Detection of potential adverse events
- Extraction of facts from academic publications
- Analysis of call center transcripts
- Survey data analysis
- Medical device repair notes analysis
- Competitive intelligence
- Social media analysis
Presenters will discuss the underworkings and practical implementations of advanced computational linguistics techniques, as well as the foundations of systems for the analysis of BIG DATA. Topics will be presented by data and text analysis specialists with relevant domain expertise. The webinar series is scheduled to run from January to April 2017.
The webinars will provide business practitioners with a clear understanding of frequently encountered individual tasks and outline the technology, implementation path, results, and benefits of the analytical solutions developed at industry-leading companies for addressing these tasks.
For more information and to register for the webinars, visit www.polyanalyst.com/webinars. Advance registration is encouraged, as availability is limited for each webinar.
About Megaputer Intelligence
Megaputer Intelligence (www.megaputer.com) is a leading developer of data and text mining software and custom analytical solutions for various application domains. Megaputer analytical tools enable over 500 customers worldwide to make informed data-driven decisions.
Megaputer is a registered trademark of Megaputer Intelligence Inc. in the United States and/or other countries. The names of other companies and products mentioned herein may be the trademarks of their respective owners.